SCHEMBL2942142

SCHEMBL2942142

CCCCCCCCCCC(C)(CCO)OC(C)(CCCCCCCCCC)CCOS(=O)(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.34
CA2 P00918 9/20 0.34
CA9 Q16790 8/20 0.34
CA12 O43570 3/20 0.34
CA7 P43166 3/20 0.34
CA14 Q9ULX7 3/20 0.34
CA3 P07451 2/20 0.34
CA4 P22748 2/20 0.34
CA6 P23280 2/20 0.34
CA5A P35218 2/20 0.34
CA5B Q9Y2D0 2/20 0.34
RECQL P46063 2/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
EPHX2 P34913 1/20 0.33
BLM P54132 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1705820 0.82 LMNA (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL1705523 0.82 LMNA (0.44) TSHRMEN1KMT2ATHRBHTT
SCHEMBL258083 0.74 CA1 (0.40) CA1CA2CA9CA12CA7
Ethylene Glycol SCHEMBL17183053 0.73 CA1 (0.55) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811421 0.73 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811770 0.73 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811059 0.73 CA1 (0.43) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811316 0.73 CA1 (0.47) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19810926 0.73 CA1 (0.43) CA1CA2CA9CA12CA7
Ammonia Solution, Strong SCHEMBL19811831 0.73 CA1 (0.43) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9968535-B2 Personal care compositions comprising undecyl sulfates THE PROCTER & GAMBLE COMPANY (US) 2018-05-15 US disclosed
EP-2229134-B1 CONCENTRATED PERSONAL CLEANSING COMPOSITIONS PROCTER & GAMBLE (US) 2017-11-15 EP disclosed
EP-2203150-B1 PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES PROCTER & GAMBLE (US) 2016-06-01 EP disclosed
EP-2229134-A2 CONCENTRATED PERSONAL CLEANSING COMPOSITIONS The Procter & Gamble Company (US) 2010-09-22 EP disclosed
EP-2203150-A2 PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES The Procter & Gamble Company (US) 2010-07-07 EP disclosed
US-20090221463-A1 Concentrated Personal Cleansing Compositions THE PROCTER & GAMBLE COMPANY 2009-09-03 US disclosed
WO-2009090617-A2 CONCENTRATED PERSONAL CLEANSING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2009-07-23 WO disclosed
US-20090155383-A1 Personal Care Compositions Comprising Undecyl Sulfates THE PROCTER & GAMBLE COMPANY 2009-06-18 US disclosed
WO-2009053931-A2 PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES THE PROCTER & GAMBLE COMPANY (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090155383-A1 Personal Care Compositions Comprising Undecyl Sulfates USP25, UTS2R, USP30 CA1 4862/4885CA2 4769/4885CA9 2967/4885
US-20090221463-A1 Concentrated Personal Cleansing Compositions CUTA, UNG, MSH2 CA1 2836/4885CA2 2279/4885CA9 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.